Aydın Çiledağ

657 total citations
62 papers, 441 citations indexed

About

Aydın Çiledağ is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine and Surgery. According to data from OpenAlex, Aydın Çiledağ has authored 62 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 13 papers in Critical Care and Intensive Care Medicine and 11 papers in Surgery. Recurrent topics in Aydın Çiledağ's work include Respiratory Support and Mechanisms (13 papers), Pleural and Pulmonary Diseases (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Aydın Çiledağ is often cited by papers focused on Respiratory Support and Mechanisms (13 papers), Pleural and Pulmonary Diseases (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Aydın Çiledağ collaborates with scholars based in Türkiye, Kuwait and United States. Aydın Çiledağ's co-authors include Akın Kaya, Elif Şen, Serhat Erol, Banu Eriş Gülbay, Gökhan Çelik, İsmail Savaş, Demet Karnak, Koray Ceyhan, Çetin Atasoy and Oya Kayacan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Current Medicinal Chemistry and Nature Reviews Rheumatology.

In The Last Decade

Aydın Çiledağ

52 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aydın Çiledağ Türkiye 13 308 74 73 61 49 62 441
Benjamin Ng Australia 8 401 1.3× 48 0.6× 32 0.4× 169 2.8× 75 1.5× 14 592
Khalil Diab United States 8 138 0.4× 27 0.4× 59 0.8× 53 0.9× 15 0.3× 32 290
Stephen Fröhlich Ireland 10 161 0.5× 54 0.7× 37 0.5× 69 1.1× 11 0.2× 20 362
Carole Philipponnet France 12 138 0.4× 27 0.4× 72 1.0× 62 1.0× 38 0.8× 36 386
Catherine Read Australia 15 618 2.0× 170 2.3× 51 0.7× 184 3.0× 56 1.1× 27 759
Justin L. Ranes United States 5 220 0.7× 95 1.3× 20 0.3× 53 0.9× 15 0.3× 7 341
Shin-Yup Lee South Korea 12 100 0.3× 74 1.0× 57 0.8× 43 0.7× 21 0.4× 26 389
Pétur Hannesson Sweden 11 165 0.5× 31 0.4× 24 0.3× 103 1.7× 45 0.9× 29 394
Georgie A. Eapen United States 15 522 1.7× 69 0.9× 26 0.4× 170 2.8× 99 2.0× 44 695
Yvonne Meli United States 9 456 1.5× 19 0.3× 27 0.4× 115 1.9× 43 0.9× 17 587

Countries citing papers authored by Aydın Çiledağ

Since Specialization
Citations

This map shows the geographic impact of Aydın Çiledağ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aydın Çiledağ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aydın Çiledağ more than expected).

Fields of papers citing papers by Aydın Çiledağ

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aydın Çiledağ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aydın Çiledağ. The network helps show where Aydın Çiledağ may publish in the future.

Co-authorship network of co-authors of Aydın Çiledağ

This figure shows the co-authorship network connecting the top 25 collaborators of Aydın Çiledağ. A scholar is included among the top collaborators of Aydın Çiledağ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aydın Çiledağ. Aydın Çiledağ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Erol, Serhat, Aydın Çiledağ, Banu Eriş Gülbay, et al.. (2025). Potential benefit of anticoagulation in Behçet syndrome. Nature Reviews Rheumatology. 21(12). 754–754.
3.
Doğan, Özlem, et al.. (2024). Immature platelet fraction as a systemic inflammation marker in patients with chronic obstructive pulmonary disease. International Journal of Laboratory Hematology. 46(5). 822–829.
4.
Erol, Serhat, Aydın Çiledağ, Koray Ceyhan, et al.. (2024). Importance of mediastinal granulomatous/sarcoid‐like lymphadenopathy in extrathoracic malignancies. Diagnostic Cytopathology. 52(9). 475–479.
5.
Erol, Serhat, et al.. (2024). Intercostal Muscle Function During Noninvasive Ventilation and Acute Hypercapnic Respiratory Failure. Respiratory Care. 69(8). 982–989.
6.
Erol, Serhat, et al.. (2023). Prognosis of lung cancer patients followed in the intensive care unit: A cross-sectional study. Tuberkuloz ve Toraks. 71(2). 138–147. 1 indexed citations
7.
Erol, Serhat, et al.. (2021). A new device for bronchoscopy for better protection. TURKISH JOURNAL OF MEDICAL SCIENCES. 52(2). 361–369. 1 indexed citations
8.
9.
Erol, Serhat, Çağlar Uzun, Zeynep Ceren Karahan, et al.. (2020). Successful treatment of COVID-19 infection in a patient with tracheostomy. Tuberkuloz ve Toraks. 68(4). 444–448. 1 indexed citations
10.
Erol, Serhat, et al.. (2020). High flow nasal cannula in COVID-19: a literature review. Tuberkuloz ve Toraks. 68(2). 168–174. 29 indexed citations
11.
Erol, Serhat, et al.. (2020). Prone positioning in non-intubated patients with COVID-19. Tuberkuloz ve Toraks. 68(3). 331–336. 19 indexed citations
12.
13.
Doğan, Özlem, et al.. (2018). The diagnostic role of pentraxin-3 in the differential diagnosis of pleural effusions. TURKISH JOURNAL OF MEDICAL SCIENCES. 48(6). 1167–1174. 2 indexed citations
14.
Çiledağ, Aydın, Gökhan Çelik, Nalan Demir, et al.. (2018). High serum YKL-40 level is associated with poor prognosis in patients with lung cancer. Tuberkuloz ve Toraks. 66(4). 273–279. 5 indexed citations
15.
Çiledağ, Aydın, et al.. (2017). Evaluation of coexistence of cancer and active tuberculosis; 16 case series. Respiratory Medicine Case Reports. 23. 33–37. 14 indexed citations
16.
Çiledağ, Aydın, et al.. (2016). Retrospective analysis of seven breast tuberculosis cases. Experimental and Therapeutic Medicine. 12(5). 3053–3057. 6 indexed citations
17.
Çiledağ, Aydın, Nalan Demir, Gökhan Çelik, et al.. (2015). Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer. Tuberkuloz ve Toraks. 63(2). 71–77. 7 indexed citations
18.
Çiledağ, Aydın, et al.. (2011). SCROFULODERMA IN AN OLDER PATIENT: AN UNDERESTIMATED ENTITY AND UNDERDIAGNOSED CASE. The Turkish Journal of Geriatrics. 14(2).
19.
20.
Kaya, Akın, Aydın Çiledağ, Banu Eriş Gülbay, et al.. (2004). The prognostic significance of vascular endothelial growth factor levels in sera of non-small cell lung cancer patients. Respiratory Medicine. 98(7). 632–636. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Ng Breakdown of academic impact, for papers by Khalil Diab Breakdown of academic impact, for papers by Stephen Fröhlich Breakdown of academic impact, for papers by Carole Philipponnet Breakdown of academic impact, for papers by Catherine Read Breakdown of academic impact, for papers by Justin L. Ranes Breakdown of academic impact, for papers by Shin-Yup Lee Breakdown of academic impact, for papers by Pétur Hannesson Breakdown of academic impact, for papers by Georgie A. Eapen Breakdown of academic impact, for papers by Yvonne Meli
Rankless by CCL
2026